The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Affiliations

¹ Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA. Electronic address: matthew.cooperberg@ucsf.edu.
² Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
³ Department of Urology, University of California, Davis, Sacramento, CA, USA.
⁴ Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁵ MD Anderson Cancer Center, Houston, TX, USA.
⁶ Department of Surgery, University of Chicago, Chicago, IL, USA.
⁷ Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Radiation Oncology, University of California, San Francisco, CA, USA.
⁸ Department of Urology, University of Washington and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁹ University of Michigan Department of Urology, Ann Arbor, MI, USA.
¹⁰ Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹¹ Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
¹² NYU Langone Health, New York, NY, USA.
¹³ Department of Urology, Vanderbilt University School of Medicine, Nashville, TN, USA; Tennessee Valley Health Care System, Nashville, TN, USA.

PMID: 31128968
DOI: 10.1016/j.eururo.2019.05.013

Editorial

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Matthew R Cooperberg et al. Eur Urol. 2019 Sep.

. 2019 Sep;76(3):268-272.

doi: 10.1016/j.eururo.2019.05.013. Epub 2019 May 23.

Authors

Affiliations

¹ Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California, San Francisco, CA, USA. Electronic address: matthew.cooperberg@ucsf.edu.
² Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
³ Department of Urology, University of California, Davis, Sacramento, CA, USA.
⁴ Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
⁵ MD Anderson Cancer Center, Houston, TX, USA.
⁶ Department of Surgery, University of Chicago, Chicago, IL, USA.
⁷ Department of Urology, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA; Department of Radiation Oncology, University of California, San Francisco, CA, USA.
⁸ Department of Urology, University of Washington and Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
⁹ University of Michigan Department of Urology, Ann Arbor, MI, USA.
¹⁰ Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹¹ Department of Radiation Oncology, University of Michigan School of Medicine, Ann Arbor, MI, USA.
¹² NYU Langone Health, New York, NY, USA.
¹³ Department of Urology, Vanderbilt University School of Medicine, Nashville, TN, USA; Tennessee Valley Health Care System, Nashville, TN, USA.

PMID: 31128968
DOI: 10.1016/j.eururo.2019.05.013

Abstract

We convened a multidisciplinary expert panel to make recommendations on current utility and future research needs for post-diagnosis prostate cancer biomarkers. The San Francisco Consensus Statement reflects on the rapid recent progress achieved, and the substantial work still ahead.

Published by Elsevier B.V.

PubMed Disclaimer

Cited by

Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer.
Sopyllo K, Erickson AM, Mirtti T. Sopyllo K, et al. Cancers (Basel). 2021 Feb 5;13(4):628. doi: 10.3390/cancers13040628. Cancers (Basel). 2021. PMID: 33562508 Free PMC article. Review.
How should radiologists incorporate non-imaging prostate cancer biomarkers into daily practice?
Rajwa P, Syed J, Leapman MS. Rajwa P, et al. Abdom Radiol (NY). 2020 Dec;45(12):4031-4039. doi: 10.1007/s00261-020-02496-5. Abdom Radiol (NY). 2020. PMID: 32232525 Free PMC article. Review.
Data-driven translational prostate cancer research: from biomarker discovery to clinical decision.
Lin Y, Zhao X, Miao Z, Ling Z, Wei X, Pu J, Hou J, Shen B. Lin Y, et al. J Transl Med. 2020 Mar 7;18(1):119. doi: 10.1186/s12967-020-02281-4. J Transl Med. 2020. PMID: 32143723 Free PMC article. Review.
Laboratory-wide association study of survival with prostate cancer.
Sohlberg EM, Thomas IC, Yang J, Kapphahn K, Velaer KN, Goldstein MK, Wagner TH, Chertow GM, Brooks JD, Patel CJ, Desai M, Leppert JT. Sohlberg EM, et al. Cancer. 2021 Apr 1;127(7):1102-1113. doi: 10.1002/cncr.33341. Epub 2020 Nov 25. Cancer. 2021. PMID: 33237577 Free PMC article.
Use of the Decipher genomic classifier among men with prostate cancer in the United States.
Zaorsky NG, Proudfoot JA, Jia AY, Zuhour R, Vince R Jr, Liu Y, Zhao X, Hu J, Schussler NC, Stevens JL, Bentler S, Cress RD, Doherty JA, Durbin EB, Gershman S, Cheng I, Gonsalves L, Hernandez BY, Liu L, Morawski BM, Schymura M, Schwartz SM, Ward KC, Wiggins C, Wu XC, Shoag JE, Ponsky L, Dal Pra A, Schaeffer EM, Ross AE, Sun Y, Davicioni E, Petkov V, Spratt DE. Zaorsky NG, et al. JNCI Cancer Spectr. 2023 Aug 31;7(5):pkad052. doi: 10.1093/jncics/pkad052. JNCI Cancer Spectr. 2023. PMID: 37525535 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Affiliations

The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement

Authors

Affiliations

Abstract

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Medical